Early development of the gut microbiome and immune-mediated childhood disorders

Seminars in Reproductive Medicine

Volumn 32, Issue 1, 2014, Pages 74-86

  Li, Min ^a   Wang, Mei ^a   Donovan, Sharon M ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

allergy; asthma; gastrointestinal; immune; microbiota

Indexed keywords

PREBIOTIC AGENT; PROBIOTIC AGENT; ANTIINFECTIVE AGENT;

ADAPTIVE IMMUNITY; ALLERGIC DISEASE; AMNION FLUID; ARTICLE; ARTIFICIAL MILK; ASTHMA; ATOPOBIUM; ATOPY; BREAST FEEDING; BREAST MILK; CESAREAN SECTION; CHILDHOOD DISEASE; CLOSTRIDIUM; DELIVERY; ECZEMA; ENTEROCOCCUS; ENVIRONMENTAL EXPOSURE; ESCHERICHIA COLI; FECES MICROFLORA; FETUS MEMBRANE; FOOD ALLERGY; GESTATIONAL AGE; HUMAN; IMMUNE MEDIATED CHILDHOOD DISORDER; IMMUNE RESPONSE; INFLAMMATORY BOWEL DISEASE; INTESTINE FLORA; IRRITABLE COLON; KLEBSIELLA; LACTIC ACID BACTERIUM; LACTOBACILLUS; MECONIUM; MICROBIAL COLONIZATION; MICROBIAL DIVERSITY; MORTALITY; NECROTIZING ENTEROCOLITIS; PLACENTA; PRENATAL EXPOSURE; PREVOTELLA; PROTEOBACTERIA; REGULATORY T LYMPHOCYTE; STAPHYLOCOCCUS; STREPTOCOCCUS MITIS; STREPTOCOCCUS PYOGENES; UMBILICAL CORD BLOOD; CHILD; DIET; FEMALE; GASTROINTESTINAL TRACT; GENETICS; GROWTH, DEVELOPMENT AND AGING; IMMUNE SYSTEM DISEASES; IMMUNOLOGY; MICROBIOLOGY; MICROFLORA; NEWBORN; PREGNANCY;

ANTI-BACTERIAL AGENTS; CHILD; DELIVERY, OBSTETRIC; DIET; FEMALE; GASTROINTESTINAL TRACT; GESTATIONAL AGE; HUMANS; IMMUNE SYSTEM DISEASES; INFANT, NEWBORN; MICROBIOTA; PREGNANCY; PROBIOTICS;

EID: 84891787595     PISSN: 15268004     EISSN: 15264564     Source Type: Journal    
DOI: 10.1055/s-0033-1361825     Document Type: Article

References (169)

1. Rautava S., Isolauri E. The development of gut immune responses and gut microbiota: effects of probiotics in prevention and treatment of allergic disease. Curr Issues Intest Microbiol: 2002; 3 1 15 22 (Pubitemid 34520952)
2. Donovan S. Role of human milk components in gastrointestinal development: Current knowledge and future NEEDS. J Pediatr: 2006; 149 5 S49 S61 (Pubitemid 44278858)
3. Field C. J. The immunological components of human milk and their effect on immune development in infants. J Nutr: 2005; 135 1 1 4 (Pubitemid 40094311)
4. Azad M. B., Kozyrskyj A. L. Perinatal programming of asthma: the role of gut microbiota. Clin Dev Immunol: 2012; 2012 932072
5. Forchielli M. L., Walker W. A. The role of gut-associated lymphoid tissues and mucosal defence. Br J Nutr: 2005; 93 01 S41 S48 (Pubitemid 43073406)
6. Dupaul-Chicoine J., Dagenais M., Saleh M. Crosstalk between the intestinal microbiota and the innate immune system in intestinal homeostasis and inflammatory bowel disease. Inflamm Bowel Dis: 2013; 19 10 2227 2237
7. Mackie R. I., Sghir A., Gaskins H. R. Developmental microbial ecology of the neonatal gastrointestinal tract. Am J Clin Nutr: 1999; 69 5 1035S 1045S (Pubitemid 29205082)
8. Palmer C., Bik E. M., DiGiulio D. B., Relman D. A., Brown P. O. Development of the human infant intestinal microbiota. PLoS Biol: 2007; 5 7 e177
9. Iebba V., Aloi M., Civitelli F., Cucchiara S. Gut microbiota and pediatric disease. Dig Dis: 2011; 29 6 531 539
10. Weber T. K., Polanco I. Gastrointestinal microbiota and some children diseases: a review. Gastroenterol Res Pract: 2012; 2012 676585
11. Snyder M. The bacterial flora of meconium specimens collected from sixty-four infants within four hours after delivery. J Pediatr: 1936; 9 5 624 632
12. Jiménez E., Marín M. L., Martín R., et al. Is meconium from healthy newborns actually sterile? Res Microbiol: 2008; 159 3 187 193
13. DiGiulio D. B. Diversity of microbes in amniotic fluid. Semin Fetal Neonatal Med: 2012; 17 1 2 11
14. DiGiulio D. B., Romero R., Amogan H. P., et al. Microbial prevalence, diversity and abundance in amniotic fluid during preterm labor: a molecular and culture-based investigation. PLoS ONE: 2008; 3 8 e3056
15. Steel J. H., Malatos S., Kennea N., et al. Bacteria and inflammatory cells in fetal membranes do not always cause preterm labor. Pediatr Res: 2005; 57 3 404 411 (Pubitemid 40293609)
16. Jiménez E., Fernández L., Marín M. L., et al. Isolation of commensal bacteria from umbilical cord blood of healthy neonates born by cesarean section. Curr Microbiol: 2005; 51 4 270 274 (Pubitemid 41426207)
17. Satokari R., Grönroos T., Laitinen K., Salminen S., Isolauri E. Bifidobacterium and Lactobacillus DNA in the human placenta. Lett Appl Microbiol: 2009; 48 1 8 12
18. Pettker C. M., Buhimschi I. A., Magloire L. K., Sfakianaki A. K., Hamar B. D., Buhimschi C. S. Value of placental microbial evaluation in diagnosing intra-amniotic infection. Obstet Gynecol: 2007; 109 3 739 749 (Pubitemid 46339416)
19. Martin R., Langa S., Reviriego C., et al. The commensal microflora of human milk: New perspectives for food bacteriotherapy and probiotics. Trends Food Sci Technol: 2004; 14 121 127 (Pubitemid 38300183)
20. Thum C., Cookson A. L., Otter D. E., et al. Can nutritional modulation of maternal intestinal microbiota influence the development of the infant gastrointestinal tract? J Nutr: 2012; 142 11 1921 1928
21. Bearfield C., Davenport E. S., Sivapathasundaram V., Allaker R. P. Possible association between amniotic fluid micro-organism infection and microflora in the mouth. BJOG: 2002; 109 5 527 533 (Pubitemid 37337993)
22. Wagner C. L., Taylor S. N., Johnson D. Host factors in amniotic fluid and breast milk that contribute to gut maturation. Clin Rev Allergy Immunol: 2008; 34 2 191 204
23. Blakey J. L., Lubitz L., Barnes G. L., Bishop R. F., Campbell N. T., Gillam G. L. Development of gut colonisation in pre-term neonates. J Med Microbiol: 1982; 15 4 519 529 (Pubitemid 13196463)
24. Magne F., Abély M., Boyer F., Morville P., Pochart P., Suau A. Low species diversity and high interindividual variability in faeces of preterm infants as revealed by sequences of 16S rRNA genes and PCR-temporal temperature gradient gel electrophoresis profiles. FEMS Microbiol Ecol: 2006; 57 1 128 138 (Pubitemid 43880249)
25. Sakata H., Yoshioka H., Fujita K. Development of the intestinal flora in very low birth weight infants compared to normal full-term newborns. Eur J Pediatr: 1985; 144 2 186 190 (Pubitemid 15007000)
26. Gewolb I. H., Schwalbe R. S., Taciak V. L., Harrison T. S., Panigrahi P. Stool microflora in extremely low birthweight infants. Arch Dis Child Fetal Neonatal Ed: 1999; 80 3 F167 F173 (Pubitemid 29453033)
27. Westerbeek E. A., van den Berg A., Lafeber H. N., Knol J., Fetter W. P., van Elburg R. M. The intestinal bacterial colonisation in preterm infants: a review of the literature. Clin Nutr: 2006; 25 3 361 368 (Pubitemid 43843032)
28. Butel M. J., Suau A., Campeotto F., et al. Conditions of bifidobacterial colonization in preterm infants: a prospective analysis. J Pediatr Gastroenterol Nutr: 2007; 44 5 577 582 (Pubitemid 46684358)
29. Jacquot A., Neveu D., Aujoulat F., et al. Dynamics and clinical evolution of bacterial gut microflora in extremely premature patients. J Pediatr: 2011; 158 3 390 396
30. Scholtens P. A., Oozeer R., Martin R., Amor K. B., Knol J. The early settlers: intestinal microbiology in early life. Annu Rev Food Sci Technol: 2012; 3 425 447
31. Claud E. C., Walker W. A. Hypothesis: inappropriate colonization of the premature intestine can cause neonatal necrotizing enterocolitis. FASEB J: 2001; 15 8 1398 1403 (Pubitemid 32531817)
32. Mai V., Young C. M., Ukhanova M., et al. Fecal microbiota in premature infants prior to necrotizing enterocolitis. PLoS ONE: 2011; 6 6 e20647
33. Dominguez-Bello M. G., Costello E. K., Contreras M., et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci U S A: 2010; 107 26 11971 11975
34. Biasucci G., Benenati B., Morelli L., Bessi E., Boehm G. Cesarean delivery may affect the early biodiversity of intestinal bacteria. J Nutr: 2008; 138 9 1796S 1800S
35. Penders J., Thijs C., Vink C., et al. Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics: 2006; 118 2 511 521 (Pubitemid 46085405)
36. Harmsen H. J., Wildeboer-Veloo A. C., Raangs G. C., et al. Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods. J Pediatr Gastroenterol Nutr: 2000; 30 1 61 67 (Pubitemid 30349947)
37. Yatsunenko T., Rey F. E., Manary M. J., et al. Human gut microbiome viewed across age and geography. Nature: 2012; 486 7402 222 227
38. Adlerberth I., Wold A. E. Establishment of the gut microbiota in Western infants. Acta Paediatr: 2009; 98 2 229 238
39. Kunz C., Rudloff S., Baier W., Klein N., Strobel S. Oligosaccharides in human milk: structural, functional, and metabolic aspects. Annu Rev Nutr: 2000; 20 699 722
40. Martín-Sosa S., Martín M. J., García-Pardo L. A., Hueso P. Sialyloligosaccharides in human and bovine milk and in infant formulas: variations with the progression of lactation. J Dairy Sci: 2003; 86 1 52 59 (Pubitemid 39067160)
41. Marcobal A., Barboza M., Froehlich J. W., et al. Consumption of human milk oligosaccharides by gut-related microbes. J Agric Food Chem: 2010; 58 9 5334 5340
42. Marcobal A., Barboza M., Sonnenburg E. D., et al. Bacteroides in the infant gut consume milk oligosaccharides via mucus-utilization pathways. Cell Host Microbe: 2011; 10 5 507 514
43. Fernández L., Langa S., Martín V., et al. The human milk microbiota: origin and potential roles in health and disease. Pharmacol Res: 2013; 69 1 1 10
44. Koenig J. E., Spor A., Scalfone N., et al. Succession of microbial consortia in the developing infant gut microbiome. Proc Natl Acad Sci U S A: 2011; 108 01 4578 4585
45. Fallani M., Amarri S., Uusijarvi A., et al. INFABIO team. Determinants of the human infant intestinal microbiota after the introduction of first complementary foods in infant samples from five European centres. Microbiology: 2011; 157 Pt 5 1385 1392
46. Roberfroid M., Gibson G. R., Hoyles L., et al. Prebiotic effects: metabolic and health benefits. Br J Nutr: 2010; 104 02 S1 S63
47. Haarman M., Knol J. Quantitative real-time PCR assays to identify and quantify fecal Bifidobacterium species in infants receiving a prebiotic infant formula. Appl Environ Microbiol: 2005; 71 5 2318 2324 (Pubitemid 40646972)
48. Veereman G. Pediatric applications of inulin and oligofructose. J Nutr: 2007; 137 (11, Suppl): 2585S 2589S (Pubitemid 350058741)
49. Salvini F., Riva E., Salvatici E., et al. A specific prebiotic mixture added to starting infant formula has long-lasting bifidogenic effects. J Nutr: 2011; 141 7 1335 1339
50. Shadid R., Haarman M., Knol J., et al. Effects of galactooligosaccharide and long-chain fructooligosaccharide supplementation during pregnancy on maternal and neonatal microbiota and immunity - a randomized, double-blind, placebo-controlled study. Am J Clin Nutr: 2007; 86 5 1426 1437 (Pubitemid 350126248)
51. Food and Agriculture Organization/World Health Organization Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria. 2001;. Available at: http://www.who.int/foodsafety/ publications/s-management/probiotics/en/. Accessed on December 3, 2013
52. Grześkowiak L., Grönlund M. M., Beckmann C., Salminen S., von Berg A., Isolauri E. The impact of perinatal probiotic intervention on gut microbiota: double-blind placebo-controlled trials in Finland and Germany. Anaerobe: 2012; 18 1 7 13
53. Tanaka S., Kobayashi T., Songjinda P., et al. Influence of antibiotic exposure in the early postnatal period on the development of intestinal microbiota. FEMS Immunol Med Microbiol: 2009; 56 1 80 87
54. Fouhy F., Guinane C. M., Hussey S., et al. High-throughput sequencing reveals the incomplete, short-term recovery of infant gut microbiota following parenteral antibiotic treatment with ampicillin and gentamicin. Antimicrob Agents Chemother: 2012; 56 11 5811 5820
55. Van de Merwe J. P., Stegeman J. H., Hazenberg M. P. The resident faecal flora is determined by genetic characteristics of the host. Implications for Crohn's disease? Antonie van Leeuwenhoek: 1983; 49 2 119 124 (Pubitemid 13045727)
56. Stewart J. A., Chadwick V. S., Murray A. Investigations into the influence of host genetics on the predominant eubacteria in the faecal microflora of children. J Med Microbiol: 2005; 54 Pt 12 1239 1242 (Pubitemid 41783834)
57. Zoetendal E. G., Akkermans A. DL, Akkermans-van Vliet W. M., de Visser J. AGM, de Vos W. M. The host genotype affects the bacterial community in the human gastrointestinal tract. Microb Ecol Health Dis: 2001; 13 3 129 134 (Pubitemid 32905860)
58. Turnbaugh P. J., Hamady M., Yatsunenko T., et al. A core gut microbiome in obese and lean twins. Nature: 2009; 457 7228 480 484
59. Benson A. K., Kelly S. A., Legge R., et al. Individuality in gut microbiota composition is a complex polygenic trait shaped by multiple environmental and host genetic factors. Proc Natl Acad Sci U S A: 2010; 107 44 18933 18938
60. McKnite A. M., Perez-Munoz M. E., Lu L., et al. Murine gut microbiota is defined by host genetics and modulates variation of metabolic traits. PLoS ONE: 2012; 7 6 e39191
61. Kaplan J. L., Shi H. N., Walker W. A. The role of microbes in developmental immunologic programming. Pediatr Res: 2011; 69 6 465 472
62. Vael C., Desager K. The importance of the development of the intestinal microbiota in infancy. Curr Opin Pediatr: 2009; 21 6 794 800
63. Murgas Torrazza R., Neu J. The developing intestinal microbiome and its relationship to health and disease in the neonate. J Perinatol: 2011; 31 01 S29 S34
64. Lai C. K., Beasley R., Crane J., Foliaki S., Shah J., Weiland S.; International Study of Asthma and Allergies in Childhood Phase Three Study Group. Global variation in the prevalence and severity of asthma symptoms: phase three of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax: 2009; 64 6 476 483
65. Mannino D. M., Homa D. M., Pertowski C. A., et al. Surveillance for asthma - United States, 1960-1995. MMWR CDC Surveill Summ: 1998; 47 1 1 27
66. Beasley R., Crane J., Lai C. K., Pearce N. Prevalence and etiology of asthma. J Allergy Clin Immunol: 2000; 105 2, Pt 2 S466 S472 (Pubitemid 30109009)
67. Asher M. I., Keil U., Anderson H. R., et al. International study of asthma and allergies in childhood (ISAAC): rationale and methods. Eur Respir J: 1995; 8 3 483 491
68. Strachan D. P. Hay fever, hygiene, and household size. BMJ: 1989; 299 6710 1259 1260 (Pubitemid 19280051)
69. Björkstén B., Naaber P., Sepp E., Mikelsaar M. The intestinal microflora in allergic Estonian and Swedish 2-year-old children. Clin Exp Allergy: 1999; 29 3 342 346 (Pubitemid 29145134)
70. Fukuda S., Ishikawa H., Koga Y., et al. Allergic symptoms and microflora in schoolchildren. J Adolesc Health: 2004; 35 2 156 158 (Pubitemid 38916859)
71. Kalliomäki M., Kirjavainen P., Eerola E., Kero P., Salminen S., Isolauri E. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J Allergy Clin Immunol: 2001; 107 1 129 134 (Pubitemid 32105256)
72. Penders J., Thijs C., van den Brandt P. A., et al. Gut microbiota composition and development of atopic manifestations in infancy: the KOALA Birth Cohort Study. Gut: 2007; 56 5 661 667 (Pubitemid 46662932)
73. Rautava S., Kalliomäki M., Isolauri E. New therapeutic strategy for combating the increasing burden of allergic disease: Probiotics-A Nutrition, Allergy, Mucosal Immunology and Intestinal Microbiota (NAMI) Research Group report. J Allergy Clin Immunol: 2005; 116 1 31 37 (Pubitemid 40909743)
74. Huffnagle G. B. The microbiota and allergies/asthma. PLoS Pathog: 2010; 6 5 e1000549
75. Noverr M. C., Huffnagle G. B. The 'microflora hypothesis' of allergic diseases. Clin Exp Allergy: 2005; 35 12 1511 1520
76. Vael C., Vanheirstraeten L., Desager K. N., Goossens H. Denaturing gradient gel electrophoresis of neonatal intestinal microbiota in relation to the development of asthma. BMC Microbiol: 2011; 11 68 2180
77. Thavagnanam S., Fleming J., Bromley A., Shields M. D., Cardwell C. R. A meta-analysis of the association between Caesarean section and childhood asthma. Clin Exp Allergy: 2008; 38 4 629 633 (Pubitemid 351406059)
78. Bager P., Melbye M., Rostgaard K., Benn C. S., Westergaard T. Mode of delivery and risk of allergic rhinitis and asthma. J Allergy Clin Immunol: 2003; 111 1 51 56 (Pubitemid 36143291)
79. van Nimwegen F. A., Penders J., Stobberingh E. E., et al. Mode and place of delivery, gastrointestinal microbiota, and their influence on asthma and atopy. J Allergy Clin Immunol: 2011; 128 5 948 955, e1-e3
80. Mai X. M., Kull I., Wickman M., Bergström A. Antibiotic use in early life and development of allergic diseases: respiratory infection as the explanation. Clin Exp Allergy: 2010; 40 8 1230 1237
81. Jedrychowski W., Perera F., Maugeri U., et al. Wheezing and asthma may be enhanced by broad spectrum antibiotics used in early childhood. Concept and results of a pharmacoepidemiology study. J Physiol Pharmacol: 2011; 62 2 189 195
82. Russell S. L., Gold M. J., Hartmann M., et al. Early life antibiotic-driven changes in microbiota enhance susceptibility to allergic asthma. EMBO Rep: 2012; 13 5 440 447
83. Kull I., Melen E., Alm J., et al. Breast-feeding in relation to asthma, lung function, and sensitization in young schoolchildren. J Allergy Clin Immunol: 2010; 125 5 1013 1019
84. Kusunoki T., Morimoto T., Nishikomori R., et al. Breastfeeding and the prevalence of allergic diseases in schoolchildren: does reverse causation matter? Pediatr Allergy Immunol: 2010; 21 (1, Pt 1): 60 66
85. Pohlabeln H., Mühlenbruch K., Jacobs S., Böhmann H. Frequency of allergic diseases in 2-year-old children in relationship to parental history of allergy and breastfeeding. J Investig Allergol Clin Immunol: 2010; 20 3 195 200
86. Wright A. L., Holberg C. J., Taussig L. M., Martinez F. Maternal asthma status alters relation of infant feeding to asthma in childhood. Adv Exp Med Biol: 2000; 478 131 137 (Pubitemid 32174586)
87. Grönlund M. M., Gueimonde M., Laitinen K., et al. Maternal breast-milk and intestinal bifidobacteria guide the compositional development of the Bifidobacterium microbiota in infants at risk of allergic disease. Clin Exp Allergy: 2007; 37 12 1764 1772 (Pubitemid 350145345)
88. Asher M. I., Montefort S., Björkstén B., et al. ISAAC Phase Three Study Group. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet: 2006; 368 9537 733 743 (Pubitemid 44279052)
89. Shaw T. E., Currie G. P., Koudelka C. W., Simpson E. L. Eczema prevalence in the united states: Data from the 2003 national survey of children's health. J Invest Dermatol: 2011; 131 1 67 73
90. Gore C., Munro K., Lay C., et al. Bifidobacterium pseudocatenulatum is associated with atopic eczema: a nested case-control study investigating the fecal microbiota of infants. J Allergy Clin Immunol: 2008; 121 1 135 140
91. Wang M., Karlsson C., Olsson C., et al. Reduced diversity in the early fecal microbiota of infants with atopic eczema. J Allergy Clin Immunol: 2008; 121 1 129 134
92. Abrahamsson T. R., Jakobsson H. E., Andersson A. F., Björksté n B., Engstrand L., Jenmalm M. C. Low diversity of the gut microbiota in infants with atopic eczema. J Allergy Clin Immunol: 2012; 129 2 434 440, e1-e2
93. Ismail I. H., Oppedisano F., Joseph S. J., et al. Reduced gut microbial diversity in early life is associated with later development of eczema but not atopy in high-risk infants. Pediatr Allergy Immunol: 2012; 23 7 674 681
94. Foliaki S., Pearce N., Björkstén B., Mallol J., Montefort S., von Mutius E.; International Study of Asthma and Allergies in Childhood Phase III Study Group. Antibiotic use in infancy and symptoms of asthma, rhinoconjunctivitis, and eczema in children 6 and 7 years old: International Study of Asthma and Allergies in Childhood Phase III. J Allergy Clin Immunol: 2009; 124 5 982 989
95. Greer F. R., Sicherer S. H., Burks A. W.; American Academy of Pediatrics Committee on Nutrition; American Academy of Pediatrics Section on Allergy and Immunology. Effects of early nutritional interventions on the development of atopic disease in infants and children: the role of maternal dietary restriction, breastfeeding, timing of introduction of complementary foods, and hydrolyzed formulas. Pediatrics: 2008; 121 1 183 191
96. Ip S., Chung M., Raman G., et al. Breastfeeding and maternal and infant health outcomes in developed countries. Evid Rep Technol Assess (Full Rep): 2007; 153 1 186
97. Flohr C., Nagel G., Weinmayr G., Kleiner A., Strachan D. P., Williams H. C.; ISAAC Phase Two Study Group. Lack of evidence for a protective effect of prolonged breastfeeding on childhood eczema: lessons from the International Study of Asthma and Allergies in Childhood (ISAAC) Phase Two. Br J Dermatol: 2011; 165 6 1280 1289
98. Giwercman C., Halkjaer L. B., Jensen S. M., Bonnelykke K., Lauritzen L., Bisgaard H. Increased risk of eczema but reduced risk of early wheezy disorder from exclusive breast-feeding in high-risk infants. J Allergy Clin Immunol: 2010; 125 4 866 871
99. Gigante G., Tortora A., Ianiro G., et al. Role of gut microbiota in food tolerance and allergies. Dig Dis: 2011; 29 6 540 549
100. Thompson-Chagoyan O. C., Vieites J. M., Maldonado J., Edwards C., Gil A. Changes in faecal microbiota of infants with cow's milk protein allergy - a Spanish prospective case-control 6-month follow-up study. Pediatr Allergy Immunol: 2010; 21 (2, Pt 2): e394 e400
101. Thompson-Chagoyan O. C., Fallani M., Maldonado J., et al. Faecal microbiota and short-chain fatty acid levels in faeces from infants with cow's milk protein allergy. Int Arch Allergy Immunol: 2011; 156 3 325 332
102. Rodriguez B., Prioult G., Bibiloni R., et al. Germ-free status and altered caecal subdominant microbiota are associated with a high susceptibility to cow's milk allergy in mice. FEMS Microbiol Ecol: 2011; 76 1 133 144
103. Rodriguez B., Prioult G., Hacini-Rachinel F., et al. Infant gut microbiota is protective against cow's milk allergy in mice despite immature ileal T-cell response. FEMS Microbiol Ecol: 2012; 79 1 192 202
104. Keski-Nisula L., Karvonen A., Pfefferle P. I., Renz H., Büchele G., Pekkanen J. Birth-related factors and doctor-diagnosed wheezing and allergic sensitization in early childhood. Allergy: 2010; 65 9 1116 1125
105. Koplin J. J., Martin P. E., Tang M. LK., et al. Do factors known to alter infant microbial exposures alter the risk of food allergy and eczema in a population-based infant study? J Allergy Clin Immunol: 2012; 129 (2, Suppl): ABC231
106. Eggesbo M., Botten G., Stigum H., Nafstad P., Magnus P. Is delivery by cesarean section a risk factor for food allergy? J Allergy Clin Immunol: 2003; 112 2 420 426 (Pubitemid 36981385)
107. Eggesbo M., Botten G., Stigum H., Samuelsen S. O., Brunekreef B., Magnus P. Cesarean delivery and cow milk allergy/intolerance. Allergy: 2005; 60 9 1172 1173 (Pubitemid 41153145)
108. Carlisle E. M., Morowitz M. J. The intestinal microbiome and necrotizing enterocolitis. Curr Opin Pediatr: 2013; 25 3 382 387
109. Grishin A., Papillon S., Bell B., Wang J., Ford H. R. The role of the intestinal microbiota in the pathogenesis of necrotizing enterocolitis. Semin Pediatr Surg: 2013; 22 2 69 75
110. Mshvildadze M., Neu J., Shuster J., Theriaque D., Li N., Mai V. Intestinal microbial ecology in premature infants assessed with non-culture-based techniques. J Pediatr: 2010; 156 1 20 25
111. Normann E., Fahlén A., Engstrand L., Lilja H. E. Intestinal microbial profiles in extremely preterm infants with and without necrotizing enterocolitis. Acta Paediatr: 2013; 102 2 129 136
112. Stewart C. J., Marrs E. C., Magorrian S., et al. The preterm gut microbiota: changes associated with necrotizing enterocolitis and infection. Acta Paediatr: 2012; 101 11 1121 1127
113. Comito D., Romano C. Dysbiosis in the pathogenesis of pediatric inflammatory bowel diseases. Int J Inflamm: 2012; 2012 687143
114. Cucchiara S., Iebba V., Conte M. P., Schippa S. The microbiota in inflammatory bowel disease in different age groups. Dig Dis: 2009; 27 3 252 258
115. Aomatsu T., Imaeda H., Fujimoto T., et al. Terminal restriction fragment length polymorphism analysis of the gut microbiota profiles of pediatric patients with inflammatory bowel disease. Digestion: 2012; 86 2 129 135
116. Schwiertz A., Jacobi M., Frick J. S., Richter M., Rusch K., Köhler H. Microbiota in pediatric inflammatory bowel disease. J Pediatr: 2010; 157 2 240 244, e1
117. Michail S., Durbin M., Turner D., et al. Alterations in the gut microbiome of children with severe ulcerative colitis. Inflamm Bowel Dis: 2012; 18 10 1799 1808
118. Conte M. P., Schippa S., Zamboni I., et al. Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease. Gut: 2006; 55 12 1760 1767 (Pubitemid 44893575)
119. Negroni A., Costanzo M., Vitali R., et al. Characterization of adherent-invasive Escherichia coli isolated from pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis: 2012; 18 5 913 924
120. Bager P., Simonsen J., Nielsen N. M., Frisch M. Cesarean section and offspring's risk of inflammatory bowel disease: a national cohort study. Inflamm Bowel Dis: 2012; 18 5 857 862
121. Decker E., Engelmann G., Findeisen A., et al. Cesarean delivery is associated with celiac disease but not inflammatory bowel disease in children. Pediatrics: 2010; 125 6 e1433 e1440
122. Klement E., Cohen R. V., Boxman J., Joseph A., Reif S. Breastfeeding and risk of inflammatory bowel disease: a systematic review with meta-analysis. Am J Clin Nutr: 2004; 80 5 1342 1352
123. Barclay A. R., Russell R. K., Wilson M. L., Gilmour W. H., Satsangi J., Wilson D. C. Systematic review: the role of breastfeeding in the development of pediatric inflammatory bowel disease. J Pediatr: 2009; 155 3 421 426
124. Kronman M. P., Zaoutis T. E., Haynes K., Feng R., Coffin S. E. Antibiotic exposure and IBD development among children: a population-based cohort study. Pediatrics: 2012; 130 4 e794 e803
125. Virta L., Auvinen A., Helenius H., Huovinen P., Kolho K. L. Association of repeated exposure to antibiotics with the development of pediatric Crohn's disease - a nationwide, register-based Finnish case-control study. Am J Epidemiol: 2012; 175 8 775 784
126. Shaw S. Y., Blanchard J. F., Bernstein C. N. Association between the use of antibiotics in the first year of life and pediatric inflammatory bowel disease. Am J Gastroenterol: 2010; 105 12 2687 2692
127. Hviid A., Svanström H., Frisch M. Antibiotic use and inflammatory bowel diseases in childhood. Gut: 2011; 60 1 49 54
128. Aujnarain A., Mack D. R., Benchimol E. I. The role of the environment in the development of pediatric inflammatory bowel disease. Curr Gastroenterol Rep: 2013; 15 6 326 013
129. Longstreth G. F., Thompson W. G., Chey W. D., Houghton L. A., Mearin F., Spiller R. C. Functional bowel disorders. Gastroenterology: 2006; 130 5 1480 1491
130. Saulnier D. M., Riehle K., Mistretta T. A., et al. Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome. Gastroenterology: 2011; 141 5 1782 1791
131. Rigsbee L., Agans R., Shankar V., et al. Quantitative profiling of gut microbiota of children with diarrhea-predominant irritable bowel syndrome. Am J Gastroenterol: 2012; 107 11 1740 1751
132. Maxwell P. R., Rink E., Kumar D., Mendall M. A. Antibiotics increase functional abdominal symptoms. Am J Gastroenterol: 2002; 97 1 104 108 (Pubitemid 34059772)
133. Ismail I. H., Licciardi P. V., Tang M. L. Probiotic effects in allergic disease. J Paediatr Child Health: 2013; 49 9 709 715
134. Fiocchi A., Burks W., Bahna S. L., et al. WAO Special Committee on Food Allergy and Nutrition. Clinical use of probiotics in pediatric allergy (CUPPA): A world allergy organization position paper. World Allergy Organ J: 2012; 5 11 148 167
135. Soh S. E., Aw M., Gerez I., et al. Probiotic supplementation in the first 6 months of life in at risk Asian infants - effects on eczema and atopic sensitization at the age of 1 year. Clin Exp Allergy: 2009; 39 4 571 578
136. Taylor A. L., Dunstan J. A., Prescott S. L. Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high-risk children: a randomized controlled trial. J Allergy Clin Immunol: 2007; 119 1 184 191 (Pubitemid 46037800)
137. Boyle R. J., Ismail I. H., Kivivuori S., et al. Lactobacillus GG treatment during pregnancy for the prevention of eczema: a randomized controlled trial. Allergy: 2011; 66 4 509 516
138. West C. E., Hammarström M. L., Hernell O. Probiotics during weaning reduce the incidence of eczema. Pediatr Allergy Immunol: 2009; 20 5 430 437
139. Weston S., Halbert A., Richmond P., Prescott S. L. Effects of probiotics on atopic dermatitis: a randomised controlled trial. Arch Dis Child: 2005; 90 9 892 897 (Pubitemid 41232336)
140. Woo S. I., Kim J. Y., Lee Y. J., Kim N. S., Hahn Y. S. Effect of Lactobacillus sakei supplementation in children with atopic eczema-dermatitis syndrome. Ann Allergy Asthma Immunol: 2010; 104 4 343 348
141. Fölster-Holst R., Müller F., Schnopp N., et al. Prospective, randomized controlled trial on Lactobacillus rhamnosus in infants with moderate to severe atopic dermatitis. Br J Dermatol: 2006; 155 6 1256 1261 (Pubitemid 44730004)
142. Osborn D. A., Sinn J. K. Prebiotics in infants for prevention of allergy. Cochrane Database Syst Rev: 2013; 3 CD006474
143. Gupta P., Andrew H., Kirschner B. S., Guandalini S. Is lactobacillus GG helpful in children with Crohn's disease? Results of a preliminary, open-label study. J Pediatr Gastroenterol Nutr: 2000; 31 4 453 457
144. Bousvaros A., Guandalini S., Baldassano R. N., et al. A randomized, double-blind trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn's disease. Inflamm Bowel Dis: 2005; 11 9 833 839 (Pubitemid 41368272)
145. Prantera C., Scribano M. L., Falasco G., Andreoli A., Luzi C. Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG. Gut: 2002; 51 3 405 409
146. Rahimi R., Nikfar S., Rahimi F., et al. A meta-analysis on the efficacy of probiotics for maintenance of remission and prevention of clinical and endoscopic relapse in Crohn's disease. Dig Dis Sci: 2008; 53 9 2524 2531
147. Miele E., Pascarella F., Giannetti E., Quaglietta L., Baldassano R. N., Staiano A. Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis. Am J Gastroenterol: 2009; 104 2 437 443
148. Huynh H. Q., deBruyn J., Guan L., et al. Probiotic preparation VSL#3 induces remission in children with mild to moderate acute ulcerative colitis: a pilot study. Inflamm Bowel Dis: 2009; 15 5 760 768
149. Tursi A., Brandimarte G., Giorgetti G. M., Forti G., Modeo M. E., Gigliobianco A. Low-dose balsalazide plus a high-potency probiotic preparation is more effective than balsalazide alone or mesalazine in the treatment of acute mild-to-moderate ulcerative colitis. Med Sci Monit: 2004; 10 11 PI126 PI131 (Pubitemid 39546045)
150. Bibiloni R., Fedorak R. N., Tannock G. W., et al. VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis. Am J Gastroenterol: 2005; 100 7 1539 1546 (Pubitemid 41032360)
151. Oliva S., Di Nardo G., Ferrari F., et al. Randomised clinical trial: the effectiveness of Lactobacillus reuteri ATCC 55730 rectal enema in children with active distal ulcerative colitis. Aliment Pharmacol Ther: 2012; 35 3 327 334
152. Floch M. H., Walker W. A., Madsen K., et al. Recommendations for probiotic use-2011 update. J Clin Gastroenterol: 2011; 45 (Suppl): S168 S171
153. Guandalini S. Update on the role of probiotics in the therapy of pediatric inflammatory bowel disease. Expert Rev Clin Immunol: 2010; 6 1 47 54
154. Welters C. F., Heineman E., Thunnissen F. B., van den Bogaard A. E., Soeters P. B., Baeten C. G. Effect of dietary inulin supplementation on inflammation of pouch mucosa in patients with an ileal pouch-anal anastomosis. Dis Colon Rectum: 2002; 45 5 621 627 (Pubitemid 34507237)
155. Mitsuyama K., Saiki T., Kanauchi O., et al. Treatment of ulcerative colitis with germinated barley foodstuff feeding: a pilot study. Aliment Pharmacol Ther: 1998; 12 12 1225 1230 (Pubitemid 28565962)
156. Lindsay J. O., Whelan K., Stagg A. J., et al. Clinical, microbiological, and immunological effects of fructo-oligosaccharide in patients with Crohn's disease. Gut: 2006; 55 3 348 355 (Pubitemid 43268272)
157. Moayyedi P., Ford A. C., Talley N. J., et al. The efficacy of probiotics
158. Whelan K. Probiotics and prebiotics in the management of irritable bowel syndrome: a review of recent clinical trials and systematic reviews. Curr Opin Clin Nutr Metab Care: 2011; 14 6 581 587
159. Huertas-Ceballos A. A., Logan S., Bennett C., Macarthur C. Dietary interventions for recurrent abdominal pain (RAP) and irritable bowel syndrome (IBS) in childhood. Cochrane Database Syst Rev: 2009; 1 CD003019
160. Francavilla R., Miniello V., Magistà A. M., et al. A randomized controlled trial of Lactobacillus GG in children with functional abdominal pain. Pediatrics: 2010; 126 6 e1445 e1452
161. Guandalini S., Magazzù G., Chiaro A., et al. VSL#3 improves symptoms in children with irritable bowel syndrome: a multicenter, randomized, placebo-controlled, double-blind, crossover study. J Pediatr Gastroenterol Nutr: 2010; 51 1 24 30
162. Staudacher H. M., Whelan K., Irving P. M., Lomer M. C. Comparison of symptom response following advice for a diet low in fermentable carbohydrates (FODMAPs) versus standard dietary advice in patients with irritable bowel syndrome. J Hum Nutr Diet: 2011; 24 5 487 495
163. Alfaleh K., Anabrees J., Bassler D., Al-Kharfi T. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev: 2011; 3 CD005496
164. Downard C. D., Renaud E., St Peter S. D., et al. 2012 American Pediatric Surgical Association Outcomes Clinical Trials Committee. Treatment of necrotizing enterocolitis: An American pediatric surgical association outcomes and clinical trials committee systematic review. J Pediatr Surg: 2012; 47 11 2111 2122
165. Fallon E. M., Nehra D., Potemkin A. K., et al. American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) Board of Directors. A.S.P.E.N. clinical guidelines: nutrition support of neonatal patients at risk for necrotizing enterocolitis. JPEN J Parenter Enteral Nutr: 2012; 36 5 506 523
166. Lee J. H. An update on necrotizing enterocolitis: pathogenesis and preventive strategies. Korean J Pediatr: 2011; 54 9 368 372
167. Vandenplas Y., De Greef E., Devreker T., Veereman-Wauters G., Hauser B. Probiotics and prebiotics in infants and children. Curr Infect Dis Rep: 2013; 15 3 251 262
168. Chapkin R. S., Zhao C., Ivanov I., et al. Noninvasive stool-based detection of infant gastrointestinal development using gene expression profiles from exfoliated epithelial cells. Am J Physiol Gastrointest Liver Physiol: 2010; 298 5 G582 G589
169. Schwartz S., Friedberg I., Ivanov I. V., et al. A metagenomic study of diet-dependent interaction between gut microbiota and host in infants reveals differences in immune response. Genome Biol: 2012; 13 4 r32 r2012